Additional file 1: of HerceptinÂŽ (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis

Wilson, Florence; Coombes, Megan; Brezden-Masley, Christine; Yurchenko, Mariya; Wylie, Quinlan; Douma, Reuben; Varu, Abhishek; Hutton, Brian; Skidmore, Becky; Cameron, Chris

doi:10.6084/m9.figshare.7345388.v1

13643_2018_854_MOESM1_ESM.docx (3.86 MB)

Additional file 1: of HerceptinÂŽ (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis

journal contribution

posted on 2018-11-14, 05:00 authored by Florence Wilson, Megan Coombes, Christine Brezden-Masley, Mariya Yurchenko, Quinlan Wylie, Reuben Douma, Abhishek Varu, Brian Hutton, Becky Skidmore, Chris Cameron

Supplementary Methods and Results. (DOCX 3954Â kb)

Funding

F. Hoffmann-La Roche

History

Usage metrics

Keywords

Early breast cancer HER2-positive breast cancer Network meta-analysis Survival Systematic review Trastuzumab

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of HerceptinÂŽ (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis

Funding

F. Hoffmann-La Roche

History

Usage metrics

Categories

Keywords

Licence

Exports